Artist

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Artist

Property Description
Active ingredient Carvedilol (a racemic mixture)
Form Oral dosage form (tablets, capsules)
Pharmacological class Alpha- and beta-adrenergic blocking agent
General purpose Management of circulatory function and systemic resistance
Origin Synthetic, highly lipophilic compound

What Type of Medicine is Artist (Carvedilol)?

The medicine Artist is a synthetic, prescription-only compound whose active ingredient is Carvedilol, fundamentally classified as an alpha-/beta-adrenergic blocking agent. This dual classification places it among the vasodilating beta-blockers, designed to modulate the effects of the body's natural stress hormones on the cardiovascular system. This mechanism is particularly valuable for improving circulatory dynamics in chronic cardiovascular management.

Carvedilol is differentiated among many older beta-blockers by its unique dual-action profile: it acts as a nonselective beta-blocker while uniquely incorporating significant alpha1-adrenergic receptor antagonism. This alpha1-blocking capability is essential for generating peripheral vasodilating effects, a feature that sets it apart from agents that focus solely on beta-receptor blockade and may increase vascular resistance.

Composition and Form: The Dual-Action Racemic Tablet

Artist is prepared for oral dosage form, typically administered as film-coated tablets or extended-release capsules. The core chemical substance, Carvedilol, is supplied as a racemic mixture, a compound containing equal amounts of the R(+) and S(–) mirror-image forms. Both R(+) and S(–) enantiomers contribute to the critical alpha1-blocking action, which is vital for the desired vessel-widening effect.

This formulation is a single-component product that is highly lipophilic, aiding its efficient absorption following oral administration. Its specific chemical structure dictates the combination of beta-blockade and vasodilation, providing a foundational action distinct from non-vasodilating beta-blockers.

What is the General Purpose of This Dual Action?

The general purpose of the medicine's dual action mechanism is to reduce the overall resistance encountered by the heart and improve the stability of the circulatory system. By simultaneously easing the heart’s contraction rate and encouraging the widening of blood vessels, Carvedilol provides a comprehensive approach to managing cardiovascular function. This fundamental regulatory effect on the circulation is specifically aimed at providing a foundation for long-lasting antihypertensive action.

What side effects are possible with Artist?

The safety profile of Artist (Carvedilol) is documented in official prescribing information, outlining the types and frequencies of adverse reactions observed during clinical use.

Classification of Officially Documented Adverse Reactions

Adverse reactions are classified based on their frequency of occurrence, primarily affecting the cardiac, nervous, and vascular systems.

Very Common Adverse Reactions

Reactions categorized as Very Common (occurring in 10% or more of patients) in regulatory labeling primarily include dizziness, headache, and general fatigue (asthenia). Cardiovascular effects in this frequency category are bradycardia (slow heart rate) and hypotension (low blood pressure).

Common Adverse Reactions

Reactions categorized as Common (occurring in 1% to less than 10% of patients) include orthostatic hypotension (dizziness upon standing) and gastrointestinal issues such as nausea, diarrhea, and vomiting. Pain in extremities and visual impairment are also documented in this category.

Serious Safety Considerations

The medicine is associated with a risk of certain serious adverse reactions. The potential for a transient worsening of heart failure is documented, particularly during the initial dose titration phase. Other serious cardiac conditions noted include atrioventricular block and severe bradycardia. Rare but severe reactions, such as severe hepatic injury and severe cutaneous adverse reactions, have also been reported.

Safety Restrictions and Time-Related Patterns

Carvedilol is contraindicated (must not be used) in patients with severe hepatic impairment, cardiogenic shock, and certain severe heart conduction abnormalities, such as third-degree AV block without a pacemaker. The most common adverse effects, including dizziness and hypotension, are noted in official labeling as being more frequently observed at the start of treatment and during any subsequent dose increase.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Artist (Carvedilol) defines the overdose profile primarily by severe, potentially life-threatening effects on the circulatory and central nervous systems.

Documented Overdose Manifestations

System Manifestations Listed in Regulatory Sources
Cardiovascular Severe hypotension (low blood pressure), profound bradycardia (slow heart rate), potential for cardiac arrest or cardiogenic shock.
CNS / Respiratory Seizures, loss of consciousness, syncope, bronchospasm (difficulty breathing), and vomiting.

When Immediate Medical Help is Required

Regulators mandate that immediate medical attention must be sought for any suspected overdose. Emergency services must be contacted immediately if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Contacting a Poison Control Center is also required for urgent guidance.

Supportive Care and Monitoring: Treatment is officially defined as symptomatic and supportive. No specific antidote is formally listed in the regulatory summary. Close observation under intensive-care conditions is required for severe manifestations to manage hemodynamic and respiratory instability.

Therapeutic Uses of Artist

The medicine Artist (Carvedilol) is commonly used across critical cardiovascular domains to provide supportive relief and long-term functional stability. It is applied to help ease symptoms in several conditions.


Artist is generally used for the long-term management of conditions characterized by increased physiological stress, primarily addressing chronic heart failure, essential hypertension (high blood pressure), and the management of patients with impaired left ventricular function following a myocardial infarction. It helps address symptom groups like shortness of breath and fluid retention, which are symptoms related to systemic imbalance.

“The primary therapeutic benefit of this medication is to provide support that helps ease the overall symptom burden and assists with maintaining functional stability during symptomatic periods.”

Quick Fact: Relief for Circulatory Stress

The medication is commonly applied in clinical settings where supportive symptom management is appropriate to stabilize the cardiovascular system post-event. By providing supportive systemic blood pressure regulation, Artist is commonly used to help with managing the physiological strain on the circulatory system and contributes to improved day-to-day comfort.

Eligibility and Restrictions for Use

Who Can and Cannot Use Artist?

The population eligibility for Artist (Carvedilol) is strictly defined by government regulatory documents, focusing on absolute contraindications and specific population restrictions.


Absolute Contraindications

Use of this medicine is contraindicated and strictly prohibited for patients with certain pre-existing conditions, including:

  • Severe hepatic impairment (severe liver dysfunction).
  • Bronchial asthma or related bronchospastic conditions.
  • Cardiogenic shock or decompensated heart failure requiring intravenous inotropic therapy.
  • Second- or third-degree AV block or severe bradycardia, unless a permanent pacemaker is in place.

Age and Reproductive Restrictions

  • Pediatric Use: Safety and efficacy have not been established in the pediatric population (children and adolescents under 18 years), and its use is not recommended.
  • Pregnancy and Lactation: Use during pregnancy is conditional and only permitted if the potential benefit justifies the potential risk to the fetus. Use is not recommended for women who are breastfeeding.
  • Conditional Use: The medicine must be used with explicit caution and monitoring in patients with conditions like diabetes mellitus or Peripheral Vascular Disease (PVD), as stated in the official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Artist (Carvedilol) around changes in plasma exposure and additive physiological effects with specific co-administered substances.

Pharmacokinetic Interactions and Exposure

The medicine is subject to metabolic interactions primarily through CYP2D6 and CYP2C9 enzyme pathways. Co-administration with CYP2C9 inhibitors, such as Amiodarone or Fluconazole, increases the concentration of the S(-) enantiomer by at least two-fold. Conversely, strong enzyme inducers like Rifampin are documented to significantly reduce overall carvedilol plasma exposure by approximately 70%.

Furthermore, Digoxin concentrations are increased by around 15% when co-administered, and Cyclosporine mean trough levels may be modestly increased. The use of Cimetidine also results in a 30% increase in carvedilol AUC.

Pharmacodynamic Effects and Restrictions

Additive effects on the cardiovascular system are documented with several agents. Concomitant use with Digitalis glycosides and certain Calcium Channel Blockers (Verapamil, Diltiazem) may lead to further slowing of atrioventricular conduction and heart rate. The intravenous co-administration of Verapamil or Diltiazem is formally prohibited due to the risk of severe hemodynamic disturbance. Additive hypotensive effects are documented with other Hypotensive Agents and Alcohol.

Administration Constraints

The oral tablet formulation must be administered with food to minimize the incidence of orthostatic effects. If co-treatment with Clonidine is terminated, the beta-blocker must be discontinued first as a mandatory sequencing rule.

Mechanism of Action

The mechanism of Carvedilol is defined by a unique dual-action blockade of the body's adrenergic receptors and an auxiliary antioxidant effect, which together influence circulatory parameters.

Dual Antagonism of alpha and beta Receptors

This core mechanism involves the nonselective antagonism of beta1 and beta2 receptors coupled with alpha1 receptor antagonism. This dual action regulates the sympathetic nervous system's influence on the cardiovascular system. Blockade of beta1 receptors in the heart leads to a direct reduction in heart rate (negative chronotropy) and a decrease in the force of contraction (negative inotropy).

Reduction of Systemic Resistance

,alpha1 antagonism prevents catecholamines from signaling the peripheral arteries to contract. This action causes vascular smooth muscle to relax, resulting in a decrease in systemic vascular resistance (SVR). This systemic effect complements the molecule's action on the heart, influencing the total circulatory resistance.

Non-Adrenergic Tissue Protection

Beyond receptor blockade, Carvedilol functions as a free radical scavenger. This secondary mechanism involves the neutralization of reactive oxygen species, which mitigates oxidative stress on endothelial and myocardial tissue. Furthermore, the molecule indirectly modulates the Renin-Angiotensin-Aldosterone System (RAAS) by limiting renin release via beta1 receptor antagonism.

Dosage and Administration Information

How to Use Artist

Artist (Carvedilol) is administered exclusively through the oral route and is available in two main forms: the Immediate-Release (IR) tablet and the Extended-Release (CR) capsule. Both formulations are taken with food to slow the absorption rate, which helps minimize specific orthostatic effects.

Dosing and Administration Protocol

The fundamental principle for its use is gradual dose titration over several weeks, a process that requires close monitoring. The therapy is intended for long-term management and must never be stopped abruptly; discontinuation must be a gradual tapering process, typically over a period of one to two weeks.

Administration Detail Immediate-Release (IR) Tablet Extended-Release (CR) Capsule
Frequency Twice daily (bid) Once daily (qd)
Starting Dose (Heart Failure) 3.125 mg bid 10 mg qd
Dose Titration Interval Not less than every two weeks Not less than every two weeks

Key Procedural Instructions

Dosage is individualized based on the indication, with maximum limits defined by the specific regimen (e.g., up to 50 mg total daily dose for hypertension). The CR capsule should be swallowed whole but can be opened and sprinkled onto a small amount of cold, soft food, such as applesauce, for immediate consumption; the capsule must not be crushed or chewed. If a dose of the IR tablet is missed, it should be taken as soon as remembered, unless it is near the time for the next dose, in which case the missed dose must be skipped. Furthermore, the medicine should not be used in patients with severe hepatic impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Artist


Evidence for use in Chronic Heart Failure

Artist has been the subject of extensive research, primarily through large-scale, controlled clinical trials involving thousands of individuals. These studies were designed to explore whether the medicine, when used alongside standard existing treatments, may be associated with heart function measurements and overall well-being in patients with chronic heart failure.

Research so far indicates that for people with mild to severe stable chronic heart failure, the medicine was monitored in trials exploring outcomes in addition to standard care. Studies monitored changes in functional capacity and collected data on long-term outcomes. Findings consistently describe patterns observed in patients receiving the medicine compared to control groups.

Evidence Following a Heart Attack with Impaired Function

This indication was explored in dedicated clinical trials focused on individuals who had recently experienced a heart attack. The research targeted patients whose heart showed reduced ability to pump blood efficiently. The studies aimed to determine if starting the medicine after the acute event might research explored how the medicine's introduction related to subsequent monitoring of the heart's status.

Findings from these controlled trials indicate that for patients who are stable after a heart attack, research describes patterns related to long-term heart function and overall status in the study populations. Research explored how the medicine's introduction related to subsequent monitoring of the heart's status.

Evidence for use in Essential Hypertension

Many different types of studies, including randomized and controlled trials, have been conducted to investigate the role of Artist in managing high blood pressure, known as essential hypertension. These studies compared the medicine with inactive substances or with other types of blood pressure medications.

Research indicates that studies monitored the medicine's association with measured reductions in blood pressure levels in adults. While studies document the measured blood pressure reductions, a key research gap is the availability of long-term comparative evidence.

Long-term Studies and Durability of Response

Clinical research for Artist has included extended observation periods to assess the durability of the observed patterns. Available evidence indicates that the outcomes observed in chronic heart failure and following a heart attack were monitored to see if the patterns persisted over several years. Patients followed for several years in clinical trials continued to show patterns related to the outcomes initially studied.

What is Still Uncertain About the Research for Artist

Even with a large amount of research available, there are still areas where evidence is limited. A key gap relates to a complete understanding of how individual factors might influence a person's study pattern response to Artist. Research is also limited in patients with very rare or complex combinations of co-existing medical conditions that were not extensively included in the original clinical trials. The evidence highlights that achieving full representation of every diverse patient population in clinical trials remains a limitation.

Key Studies & References

  1. Label: CARVEDILOL tablet, film coated - DailyMed (Authoritative Drug Labeling)

Frequently Asked Questions (FAQ)

Common questions about Artist (FAQ)

Q: How long does it typically take for the effects of Artist to become noticeable?

A: According to official product information, the full effect of Artist on blood pressure, particularly in the management of hypertension, is typically observed within one to two weeks of initiating treatment. This emphasizes that the medicine is intended for management over time rather than for immediate relief.

Q: Does Artist cause significant changes in weight or appetite?

A: Studies and official information indicate that a weight increase is a documented adverse event. This is noted as a common occurrence in certain patient populations documented in clinical data.

Q: Are there any specific over-the-counter medicines known to interact with Artist?

A: Regulatory documents note that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may potentially reduce the blood pressure lowering effect of Artist. Regulatory labeling highlights the potential for this combination to lessen the medicine’s desired effect.

Q: Is Artist classified as a controlled substance in the US or other regions?

A: According to the official US Drug Enforcement Administration (DEA) scheduling information, Artist is not currently classified as a controlled substance. It is only listed as a prescription-only compound.

Q: What is the purpose of the Black Box Warning, if Artist has one?

A: The official US FDA label for Artist does not carry a Black Box Warning (the strongest caution required by the FDA). However, the label does include prominent warnings regarding the potential risks of abruptly stopping the medicine, especially for patients with coronary artery disease.

Q: Does Artist affect the ability to operate machinery or drive?

A: Official product information notes that due to the risk of dizziness, lightheadedness, or fainting (syncope), patients should use caution when performing tasks that require mental alertness, such as driving or operating hazardous machinery, until the effects are known.

Q: Is it necessary to avoid alcohol completely while using Artist?

A: Regulatory documents state that consuming alcohol while using Artist is documented to produce an additive hypotensive effect. This means the combination may lead to an increased risk of hypotension (low blood pressure).

Q: Are there any age restrictions or special considerations for older adults using Artist?

A: Safety and effectiveness have not been established for children and adolescents under 18 years of age. For older adults, official guidance indicates that the medicine's activity in the body is generally not altered, but close patient monitoring during the initial dose titration is often necessary.

Q: What official information is available about the risk of dependency or withdrawal from Artist?

A: Official guidance mandates that the medicine must never be stopped abruptly; instead, discontinuation must occur via a gradual dose tapering process. This gradual process is required to help minimize the risk of a severe worsening of pre-existing heart conditions.

Q: What should a patient know about severe allergic reactions related to Artist?

A: Official prescribing information states that Artist is contraindicated (must not be used) in patients who have a history of a serious hypersensitivity reaction to any of its components. Examples of severe hypersensitivity reactions are noted in the prescribing information.

Q: Does taking Artist require any routine lab tests or patient monitoring?

A: Yes, the official documentation describes that patient monitoring is typically required, especially for blood pressure, heart rate, body weight (to check for fluid retention), and liver function. Additional blood sugar monitoring is necessary for patients with diabetes.

Q: What kind of kidney or liver function issues might prevent someone from using Artist?

A: Artist is contraindicated in patients with severe hepatic impairment, which is severe liver dysfunction. Official pharmacokinetic data suggests that the medicine’s profile is not significantly altered in patients who have renal (kidney) disease.

Q: What does official literature say about the half-life of Artist in the body?

A: According to official pharmacokinetic information, the elimination half-life of the active ingredient, Carvedilol, is described as being approximately 4 to 10 hours. This refers to the time it takes for half of the medicine to be cleared from the body.

Q: Does Artist have an interaction with common foods or specific juices like grapefruit?

A: The official administration protocol mandates that the medicine be taken with food to minimize specific effects. Regarding specific juices, some sources suggest that grapefruit juice may minimally increase the concentration of the medicine in the blood.

Q: Is a metallic or altered sense of taste a reported side effect of Artist?

A: Official regulatory documents describe that taste disturbance (known medically as dysgeusia) may occur. This is noted in regulatory documents as an uncommon or rare adverse reaction.

Q: Are there any documented cases where Artist interacts with herbal supplements?

A: Official documents caution that the interaction profile with herbal remedies and supplements has generally not been established in the same rigorous manner as interactions with prescription medicines. This highlights that the impact of specific herbal supplements has not been widely documented in the regulatory information.

Q: Can Artist be taken alongside other medications used for mental health conditions?

A: Regulatory labels include extensive listings of drug interactions, but the specific risks vary widely depending on the mental health medication involved. Regulatory sources indicate a possibility of additive effects on blood pressure or heart rate when combining medications.

Q: What does the patient information leaflet say about overdose symptoms for Artist?

A: Official information on overdosage states that symptoms may include severe low blood pressure (hypotension), severe slow heart rate (bradycardia), and vomiting. In severe cases, loss of consciousness and seizures are also documented.

Q: What is the evidence regarding Artist and potential for sun sensitivity or skin reactions?

A: Regulatory documents list reports of severe cutaneous adverse reactions (severe skin reactions). However, official prescribing information does not explicitly list sun sensitivity (photosensitivity) as a common or specific adverse reaction.

Q: Does Artist have any known interactions with vaccines?

A: Official regulatory drug interaction sources do not list a specific interaction with vaccines. As with any concomitant use of medications, a review by a healthcare professional is recommended.

Q: Does Artist interact with common pain relievers like ibuprofen or acetaminophen?

A: Yes, regulatory documents note that the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may reduce the blood pressure lowering effect of Artist. A specific interaction with acetaminophen is not noted in the official documents.

Q: How does Artist get eliminated from the body, according to pharmacokinetic data?

A: Pharmacokinetic data shows that Artist is primarily metabolized by liver enzymes. It is then eliminated from the body primarily through the feces (approximately 60%) and, to a lesser extent, the urine (approximately 16%).

Q: Does Artist affect fertility in men or women?

A: According to official regulatory information regarding reproduction, there is no evidence suggesting that the medicine reduces fertility in either men or women.

Q: How is the safety of Artist monitored after it has been approved and released to the public?

A: The safety profile of the medicine is continually monitored even after approval through a process known as post-marketing surveillance. This system collects and documents rare or serious adverse reactions that are reported during widespread public use.

Q: What is the relationship between Artist and changes in blood sugar levels?

A: Official documents note that caution is advised in patients with diabetes because Artist may mask symptoms of low blood sugar (hypoglycemia), such as a fast heartbeat. In some cases, it may also worsen high blood sugar (hyperglycemia).

Q: Can Artist be taken by people with a history of seizures?

A: A history of seizures is not listed as an absolute contraindication in the official prescribing information. However, patients should be aware that seizures are documented as a potential symptom in the event of an overdosage.

Q: Is the use of Artist linked to any known dental or oral health issues?

A: Official regulatory documents indicate that the effect of dry mouth (known medically as xerostomia) may occur. This is noted as an uncommon or rare adverse reaction associated with the medicine.

Q: Does Artist carry a risk of hypersensitivity reactions?

A: Yes, regulatory documentation confirms that the medicine is contraindicated (must not be used) in patients with a history of a serious hypersensitivity reaction to any of its components. Examples of severe reactions are noted in the prescribing information.

Q: Does Artist interact with common medications used for high blood pressure or diabetes?

A: Yes, official sources confirm a possibility of interactions. Combining Artist with other blood pressure lowering agents may cause additive hypotensive effects. Furthermore, when used with antidiabetic agents, Artist may make it difficult to recognize signs of low blood sugar.

How should Artist be stored and disposed of?

The storage and disposal of Artist (Carvedilol) must strictly follow the conditions specified in official regulatory labeling to ensure product integrity and safety.

Official Storage Requirements

Scope Element Requirement (Based on FDA/EMA Labeling)
Storage Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F); do not store above 30 C and keep from freezing.
Protection Must be protected from light and moisture; keep the container tightly closed and in the original, light-resistant container.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

  • Unused Product: Safely discard any medicine that is outdated or no longer needed.
  • Local Requirements: Any unused product or waste material must be disposed of in accordance with local requirements to avoid environmental contamination.

Official documents mandate specific temperature and light control, and require the medicine to be kept inaccessible to children. If the extended-release capsules are mixed with food for administration, the mixture must be consumed immediately and not stored.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Artist found in:

A-Z Index: